Yun H. Lee

Array ( [id] => 3843195 [patent_doc_number] => 05708016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Pseudopeptides derived from neurokinins' [patent_app_type] => 1 [patent_app_number] => 8/801037 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3842 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708016.pdf [firstpage_image] =>[orig_patent_app_number] => 801037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888444 [patent_doc_number] => 05714577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Antimicrobial peptides' [patent_app_type] => 1 [patent_app_number] => 8/786748 [patent_app_country] => US [patent_app_date] => 1997-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19480 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714577.pdf [firstpage_image] =>[orig_patent_app_number] => 786748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730864 [patent_doc_number] => 05693611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Cyclic peptide antifungal agents' [patent_app_type] => 1 [patent_app_number] => 8/785207 [patent_app_country] => US [patent_app_date] => 1997-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15230 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 381 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693611.pdf [firstpage_image] =>[orig_patent_app_number] => 785207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698056 [patent_doc_number] => 05677283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => '.alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. converting enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/732173 [patent_app_country] => US [patent_app_date] => 1996-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5273 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 311 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677283.pdf [firstpage_image] =>[orig_patent_app_number] => 732173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693708 [patent_doc_number] => 05679642 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Peptide-chelator conjugates' [patent_app_type] => 1 [patent_app_number] => 8/713484 [patent_app_country] => US [patent_app_date] => 1996-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4362 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679642.pdf [firstpage_image] =>[orig_patent_app_number] => 713484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3745092 [patent_doc_number] => 05801225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Sorbent families' [patent_app_type] => 1 [patent_app_number] => 8/690605 [patent_app_country] => US [patent_app_date] => 1996-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 10220 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801225.pdf [firstpage_image] =>[orig_patent_app_number] => 690605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757888 [patent_doc_number] => 05721212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Peptides for heparin and low molecular weight heparin anticoagulation reversal' [patent_app_type] => 1 [patent_app_number] => 8/677304 [patent_app_country] => US [patent_app_date] => 1996-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6921 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721212.pdf [firstpage_image] =>[orig_patent_app_number] => 677304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689419 [patent_doc_number] => 05679349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Vaccine design and production' [patent_app_type] => 1 [patent_app_number] => 8/678444 [patent_app_country] => US [patent_app_date] => 1996-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6443 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679349.pdf [firstpage_image] =>[orig_patent_app_number] => 678444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734302 [patent_doc_number] => 05665860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Human cancer inhibitory peptide amides' [patent_app_type] => 1 [patent_app_number] => 8/671121 [patent_app_country] => US [patent_app_date] => 1996-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7935 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665860.pdf [firstpage_image] =>[orig_patent_app_number] => 671121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589584 [patent_doc_number] => 05585357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Heteroaryloxymethyl ketones as interleukin-1.beta.converting enzyme inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/593773 [patent_app_country] => US [patent_app_date] => 1996-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8709 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585357.pdf [firstpage_image] =>[orig_patent_app_number] => 593773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617264 [patent_doc_number] => 05688527 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Lysine derivatives, process of preparation, uses, and compositions comprising them' [patent_app_type] => 1 [patent_app_number] => 8/590446 [patent_app_country] => US [patent_app_date] => 1996-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2167 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688527.pdf [firstpage_image] =>[orig_patent_app_number] => 590446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616976 [patent_doc_number] => 05688507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Methods and compositions for inhibiting thrombogenesis' [patent_app_type] => 1 [patent_app_number] => 8/559256 [patent_app_country] => US [patent_app_date] => 1995-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5966 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688507.pdf [firstpage_image] =>[orig_patent_app_number] => 559256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628245 [patent_doc_number] => 05686417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Peptide T and related peptides in the treatment of HTLV-1 myelopathy and multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 8/554758 [patent_app_country] => US [patent_app_date] => 1995-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5252 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686417.pdf [firstpage_image] =>[orig_patent_app_number] => 554758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623024 [patent_doc_number] => 05614649 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Multicatalytic protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/552794 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24044 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 373 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614649.pdf [firstpage_image] =>[orig_patent_app_number] => 552794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3745940 [patent_doc_number] => 05716927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Insulin analogs having a modified B-chain' [patent_app_type] => 1 [patent_app_number] => 8/531842 [patent_app_country] => US [patent_app_date] => 1995-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8933 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716927.pdf [firstpage_image] =>[orig_patent_app_number] => 531842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619726 [patent_doc_number] => 05612036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Synthetic Pseudomonas aeruginosa pilin peptide vaccine' [patent_app_type] => 1 [patent_app_number] => 8/519506 [patent_app_country] => US [patent_app_date] => 1995-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 13953 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612036.pdf [firstpage_image] =>[orig_patent_app_number] => 519506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850643 [patent_doc_number] => 05767087 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Pharmaceutical preparation for the therapy of immune deficiency conditions' [patent_app_type] => 1 [patent_app_number] => 8/486044 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3675 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767087.pdf [firstpage_image] =>[orig_patent_app_number] => 486044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695799 [patent_doc_number] => 05679784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Recombinant mutants for inducing specific immune responses' [patent_app_type] => 1 [patent_app_number] => 8/479400 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6171 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679784.pdf [firstpage_image] =>[orig_patent_app_number] => 479400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850643 [patent_doc_number] => 05767087 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Pharmaceutical preparation for the therapy of immune deficiency conditions' [patent_app_type] => 1 [patent_app_number] => 8/486044 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3675 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767087.pdf [firstpage_image] =>[orig_patent_app_number] => 486044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850629 [patent_doc_number] => 05767086 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Bone marrow stimulation by certain glutathione analogs' [patent_app_type] => 1 [patent_app_number] => 8/482645 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 5384 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767086.pdf [firstpage_image] =>[orig_patent_app_number] => 482645 [rel_patent_id] =>[rel_patent_doc_number] =>)